Since inhibition of these kinases reduced apoptosis in monocytes we suggest the possibility that inhibitors of Chk1 and Chk2 may protect monocytes during cancer treatment and compensate some of the immunosuppressive effects of chemotherapy. Here, CHEK2 is linked to cancer.